Breaking Down SRF Limited Financial Health: Key Insights for Investors

Curious whether SRF Limited (SRF.NS) is a buy, hold or watch? Start with the numbers: consolidated revenue jumped 21% year-on-year to ₹4,313 crore in Q4FY25 and full-year revenue reached ₹14,700 crore (up 12%); Q4 EBIT surged 47% to ₹906 crore while Q4 PAT climbed 60% to ₹707 crore even as annual PAT fell 6% to ₹1,250 crore - juxtaposed with a 12% reduction in long-term debt to ₹19,813 crore and a 9.9% rise in net worth to ₹12,598 crore; liquidity shows current assets up 8.5% to ₹6,129 crore and operating cash flow improved 18.8% to ₹2,500 crore despite net cash flow of ₹-65 crore, and valuation signals include Ambit's Buy call with a ₹3,025 target, an average analyst target of ₹3,174 and a market cap near ₹50,000 crore - yet risks such as inventory destocking, Chinese pricing pressure (including 16% price erosion in a key specialty chemical), FX impact and heavy capex sit alongside growth levers like a push into API starting materials (targeting 20% of the specialty segment by FY27), fluoropolymers for EV/electronics, and planned investments in low‑GWP refrigerants and packaging expansion; dive into the full analysis to see how these metrics, margins, debt dynamics and segment trends shape SRF's investment case.

SRF Limited (SRF.NS) - Revenue Analysis

• Consolidated revenue (Q4FY25): ₹4,313 crore, up 21% YoY from ₹3,570 crore in Q4FY24.
• Consolidated revenue (FY25): ₹14,700 crore, up 12% YoY vs FY24.

• Chemicals: Annual contribution of ₹6,691 crore (6% growth) kept the base stable, indicating steady demand in core chemistries.
• Packaging Films: Strong sequential and YoY traction - Q3FY25 revenue ₹1,385 crore, up 27% YoY, reflecting sustained packaging demand and pricing/volume mix improvements.
• Performance Films & Foil: Exceptional operational leverage - EBIT up 76% in FY25, signalling margin recovery and scale benefits even if absolute revenue figures are less prominent in disclosures.
• Specialty Chemicals: Softness observed in Q2FY25 with revenue declining 5% to ₹1,496 crore - potential cyclicality or product mix impact to monitor.

SRF Limited (SRF.NS) - Profitability Metrics

Key profitability indicators for SRF Limited show mixed momentum across quarterly and annual measures, with notable quarterly strength in Q4FY25 and softer full-year PAT despite growth in EBIT and stable EPS.

• Q4FY25 EBIT surged 47% year-on-year to ₹906 crore (from ₹616 crore in Q4FY24).
• FY25 annual EBIT: ₹2,336 crore, up 6% versus FY24 (FY24 EBIT ≈ ₹2,204 crore).
• Q4FY25 PAT rose 60% YoY to ₹707 crore (from ₹443 crore in Q4FY24).
• FY25 annual PAT: ₹1,250 crore, down 6% versus FY24 (FY24 PAT ≈ ₹1,331 crore).
• FY25 EBITDA: ₹2,970 crore.
• FY25 EPS: ₹42.2 per share (maintained, reflecting shareholder value focus).

• Quarterly acceleration: Q4FY25 delivered outsized EBIT and PAT growth, indicating operational leverage or one-time gains concentrated in the quarter.
• Full-year divergence: EBIT grew modestly while PAT declined, pointing to higher non-operating costs, tax effects, or exceptional items during FY25.
• Cash-profit proxy: EBITDA of ₹2,970 crore supports operating cash generation; EPS stability (₹42.2) underscores capital allocation consistency.
• Investors should reconcile quarterly strength with annual PAT contraction when assessing forward earnings quality and valuation.

Background and strategic context: SRF Limited: History, Ownership, Mission, How It Works & Makes Money

SRF Limited (SRF.NS) - Debt vs. Equity Structure

• Deleveraging: Long-term debt fell 12% year-on-year to ₹19,813 crore in FY25, a clear reduction in structural leverage.
• Equity growth: Net worth rose 9.9% to ₹12,598 crore, strengthening the equity cushion versus creditors.
• Liability mix: Total liabilities inched up 5.2% to ₹21,521 crore, indicating other liabilities or short-term obligations rose despite lower long-term borrowings.

• With gearing targeted around 0.3-0.4x for FY25-FY26, SRF shifts toward a more conservative capital structure compared with typical higher-leverage industrial peers.
• Net cash accruals above ₹1,800 crore annually support both capex and continued deleveraging, improving free cash flow generation.
• An anticipated interest coverage ratio near 10x in FY26 implies robust earnings relative to interest expense, reducing refinancing and default risk.

• Why total liabilities rose by 5.2% despite lower long-term debt - track short-term borrowings, lease liabilities, or increased payables.
• Execution of capex and working-capital management, which will determine whether cash accruals remain above projections.
• Interest rate environment and any large one-off financing events that could affect projected gearing and coverage.

SRF Limited (SRF.NS) - Liquidity and Solvency

• Current ratio (FY25) = Current assets / Current liabilities = ₹6,129 crore / ₹5,429 crore ≈ 1.13x, up from ≈1.03x in FY24.
• Working capital (FY25) = Current assets - Current liabilities = ₹700 crore, up from ₹169 crore in FY24 (₹5,649 - ₹5,480).
• Total assets increased 5.2% to ₹21,521 crore in FY25 (from ₹20,454 crore in FY24), indicating balance-sheet expansion alongside higher asset-backed operations.
• Operating cash flow strengthened materially: cash flow from operating activities rose 18.8% to ₹2,500 crore in FY25 (FY24 ≈ ₹2,106 crore).
• Investing cash flow was an outflow of ₹1,500 crore in FY25, reflecting significant capital expenditure or strategic investments.
• Net cash flow for FY25 was a small outflow of ₹65 crore, an improvement from a ₹200 crore outflow in FY24-implying financing activities were net cash outflows after strong operating cash generation and investing spend.

• Strong operating cash generation (₹2,500 crore) is the primary liquidity driver and provides headroom for CapEx and debt servicing despite negative investing cash flow.
• Working capital expansion and a current ratio ≈1.13x indicate adequate short-term coverage but limited cushion versus larger shocks-monitor receivables, payables, and inventory trends.
• Net cash outflow narrowed to ₹65 crore in FY25; financing outflows (net) imply repayments/dividends or buybacks after funding investing needs.

SRF Limited (SRF.NS) Valuation Analysis

• Ambit Capital: Buy, PT ₹3,025 - highlights 48% revenue share from chemicals.
• Average analyst price target: ₹3,174 (range: ₹2,080-₹3,842).
• Market capitalization: ~₹50,000 crore (Dec 2025).

• RoIC improved by 700 bps to 17% over FY2020-FY2022, indicating stronger capital efficiency and project returns.
• P/E one-year forward expected expansion: from 20x to 40x, reflecting either rerating for growth/quality or higher investor optimism.
• Revenue CAGR projected at 16% for FY2024-FY2037, implying significant top-line expansion baked into long-term models.

SRF Limited (SRF.NS) - Risk Factors

SRF Limited operates across Specialty Chemicals, Technical Textiles, and Packaging Films. Investors should weigh several operational, market and financial risks that could materially affect volumes, margins and near-term liquidity.

• High inventory & destocking: Persistent elevated industry inventory levels and ongoing channel destocking have pressured off-take and realizations across chemical and film segments.
• Pricing pressure from Chinese imports: Low-cost imports from China - particularly in fluorochemicals and refrigerants - have compressed domestic pricing and margins.
• Product-level price erosion: The Specialty Chemicals segment recorded price erosion of c.16% over the past 12 months in its largest product due to new Chinese capacity coming online.
• Currency exposure: FX volatility impacts reported results; a stronger USD reduced SRF's results by ₹34 crore in Q3FY25.
• Supply-demand imbalance in Films & Foil: The Performance Films & Foil business faces intermittent supply-demand mismatches, creating margin cyclicality.
• Capital expenditure and liquidity: Ongoing large-scale capex programs are expected to increase near-term cash outflows and may squeeze short-term liquidity metrics.

• Monitoring indicators for investors: inventory days, channel destocking announcements, Chinese export capacity additions, product-level price trends (especially the largest Specialty Chemical), quarterly FX swing disclosures, and capex spend versus free cash flow.
• Further context on SRF Limited's business and strategic positioning: SRF Limited: History, Ownership, Mission, How It Works & Makes Money

SRF Limited (SRF.NS) - Growth Opportunities

• API starting materials: targeted to represent ~20% of the Specialty segment by FY2027, shifting revenue mix toward higher-margin pharma inputs.
• Fluoropolymers capability build: strategic entry into EVs and electronics supply chains (adhesives, high-performance films, insulation), expected to lift specialty margins and open multi-year order books.
• Fourth-generation refrigerants: capex of ~₹1,100 crore to establish low-GWP production, targeting regulatory-driven demand in refrigeration and automotive HVAC.
• Packaging Films: reported 27% YoY revenue growth in Q3 FY25, signalling accelerating traction in flexible packaging and special barrier films.
• Performance Films & Foil: EBIT expanded 76% in FY25 vs FY24, reflecting product-mix improvements and operating leverage.
• Chemicals business: ~₹700 crore allocated in FY25 for debottlenecking and capacity expansion to capture incremental volumes and improve fixed-cost absorption.

• Specialty segment mix: % of specialty revenue from API starting materials (target ~20% by FY27).
• Capex spend vs schedule: ₹1,100 crore (refrigerants) and ~₹700 crore (chemicals) execution through FY25-FY26.
• Packaging revenue growth: sustain >20% YoY growth to drive top-line momentum.
• EBIT improvement: maintain or expand the FY25 +76% performance-films EBIT trajectory across successive quarters.
• Order intake from EV/electronics for fluoropolymers: initial contracts and MoUs in FY26 will validate market entry.